Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.
复制标题

DOI:
10.1007/s12325-018-0805-y
复制
发表时间:
2018-11
影响因子:
3.8
通讯作者:
Skolnik NS
Skolnik NS
中科院分区:
医学3区
文献类型:
--
作者:
Blonde L;Khunti K;Harris SB;Meizinger C;Skolnik NS

文献摘要

参考文献

被引文献

相似文献

在临床实践中,真实世界研究在提供治疗有效性证据方面变得越来越重要。虽然随机临床试验(RCT)是评价新治疗药物安全性和有效性的“金标准”,但严格的入选和排除标准意味着试验人群通常不能代表临床实践中遇到的患者人群。真实世界研究可能使用来自电子健康和索赔数据库的信息,这些数据库提供来自不同患者人群的大型数据集,和/或可能是观察性的,收集长期的前瞻性或回顾性数据。因此,它们可以提供有关长期安全性的信息,特别是与罕见事件有关的信息,以及药物在大型异质性人群中的有效性,以及有关使用模式和健康及经济结局的信息。本文综述了如何利用来自真实世界研究的证据来补充来自RCT的数据,以更全面地了解药物在实践中的优缺点。资金来源:Sanofi US,Inc.
Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice. While randomized clinical trials (RCTs) are the “gold standard” for evaluating the safety and efficacy of new therapeutic agents, necessarily strict inclusion and exclusion criteria mean that trial populations are often not representative of the patient populations encountered in clinical practice. Real-world studies may use information from electronic health and claims databases, which provide large datasets from diverse patient populations, and/or may be observational, collecting prospective or retrospective data over a long period of time. They can therefore provide information on the long-term safety, particularly pertaining to rare events, and effectiveness of drugs in large heterogeneous populations, as well as information on utilization patterns and health and economic outcomes. This review focuses on how evidence from real-world studies can be utilized to complement data from RCTs to gain a more complete picture of the advantages and disadvantages of medications as they are used in practice. Funding: Sanofi US, Inc.
DOI: 10.1016/j.ahj.2016.07.017
发表时间: 2016-10-01
影响因子: 4.8
作者:
Choudhry, Niteesh K.;Isaac, Thomas;Sequist, Thomas D.
通讯作者: Sequist, Thomas D.
DOI: 10.1111/dom.12438
发表时间: 2015-04-01
影响因子: 5.8
作者:
Bolli, G. B.;Riddle, M. C.;Home, P. D.
通讯作者: Home, P. D.
DOI: 10.1056/nejm200006223422506
发表时间: 2000-06-22
影响因子: 158.5
作者:
Benson, K;Hartz, AJ
通讯作者: Hartz, AJ
DOI: 10.1371/journal.pmed.1001026
发表时间: 2011-05
期刊: PLoS medicine
影响因子: 15.8
作者:
Golder S;Loke YK;Bland M
通讯作者: Bland M
DOI: 10.1056/nejmp1702071
发表时间: 2017-06-29
期刊: The New England journal of medicine
影响因子: --
作者:
Chen JH;Asch SM
通讯作者: Asch SM